Idexx Laboratories | IDXX - Equity Capital And Reserves


Idexx Laboratories reported $1.56B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Accuray USD 53.42M 8.45M Dec/2025
Align Technology USD 4.15B 100.27M Mar/2026
AngioDynamics USD 176.33M 2.52M Sep/2025
Dentsply International USD 1.32B 21M Mar/2026
Dexcom USD 2.96B 210.9M Mar/2026
Edwards Lifesciences USD 10.33B 10.1M Mar/2026
Fujifilm JPY 3.84T 119.25B Mar/2026
Globus Medical USD 4.73B 159.06M Mar/2026
Henry Schein USD 3.27B 21M Mar/2026
Idexx Laboratories USD 1.56B 49.28M Mar/2026
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.3B 212.6M Mar/2026
Integra LifeSciences USD 1.04B 1.06M Mar/2026
Intuitive Surgical USD 17.47B 349.5M Mar/2026
Masimo USD 788.9M 67.7M Mar/2026
Neogen USD 2.1B 2.09M Dec/2025
Orthofix International USD 435.19M 14.85M Mar/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
ResMed USD 6.49B 171.03M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Steris USD 7.18B 29.1M Mar/2026
Tandem Diabetes Care USD 132.4M 22.77M Mar/2026
Teleflex USD 3.08B 40.33M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Zoetis USD 3.23B 98M Mar/2026